Mandy Magbagbeolu Selected Research

hydromethylthionine

1/2022	Glutamatergic transmission and receptor expression in the synucleinopathy h-α-synL62 mouse model: Effects of hydromethylthionine.
1/2021	Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks.
1/2017	A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mandy Magbagbeolu Research Topics

Disease

2	Synucleinopathies 01/2022 - 01/2017
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2017
2	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 12/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 06/2015
1	Dementia (Dementias) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2004
1	Neoplasms (Cancer) 10/2004

Drug/Important Bio-Agent (IBA)

3	hydromethylthionineIBA 01/2022 - 01/2017
1	alpha-SynucleinIBA 01/2022
1	tau Proteins (tau Protein)IBA 12/2020
1	Memantine (Namenda)FDA Link 01/2020
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	SynucleinsIBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 06/2015
1	Biological ProductsIBA 10/2004
1	Complementary DNA (cDNA)IBA 10/2004

Therapy/Procedure

2	Therapeutics 01/2017 - 06/2015